
India Pharma Outlook’s May Edition Vol. II - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.
We aspire to become part of a unified healthcare platform where medicines, devices, diagnostics, and technology come together under one roof. That vision, grounded in science and executed with intent, positions 9M Lifesciences as a company to watch in India’s evolving healthcare landscape. - 9M Lifesciences
Bhasin Group is focused on expanding its role in turnkey healthcare solutions, where hospitals increasingly prefer a single partner to manage comprehensive supply needs. - Bhasin Group
By maintaining structured relationships with these partners, supported by financial safeguards and regular reconciliations, Gesun ensures operational efficiency and accountability across its distribution chain. - Gesun Lifesciences
Knowell Pharma Solutions addresses these challenges through a proactive and collaborative approach. The company...
| | Gesun Lifesciences | The antibiotic distribution landscape in India has evolved into a highly complex and strategically critical segment within the broader pharmaceutical ecosystem. |